Clinical Trial Update: Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia [Phase 1, Phase 2]

View source ↗

Summary

Open-label Phase 1/2 trial evaluating mRNA-3927 for propionic acidemia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Propionic Acidemia

Drugs mentioned

• mRNA-3927

Snippet

Sponsor: ModernaTX, Inc. | Conditions: Propionic Acidemia | Phase 1, Phase 2 | Status: RECRUITING